Clinical trial
TAID Study - A Prospective Interventional Trial on Antibiotics Continuous Infusion at Home
NCT04816968 is registered in ClinicalTrials.gov with Ospedale San Carlo Borromeo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TAID Study - A Prospective Interventional Trial on Antibiotics Continuous Infusion at Home
- Lead sponsor
- Ospedale San Carlo Borromeo
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 30, 2021
- Completion date
- December 31, 2023
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe bacterial infections